MentionFox
Home › Stakes › Infleqtion, Inc.
5%+ stakes · Schedule 13D and 13G

Infleqtion, Inc.: 5%+ holders

Who has reported owning 5% or more of Infleqtion, Inc., from Schedule 13D and 13G filings: each holder's stake as filed, the timeline, and the purpose each 13D states, quoted.

At 5% or more3
Filings22
Latest filing2026-06-11

Infleqtion, Inc. has 22 Schedule 13D or 13G filings on record since 2025-08-12. 3 holders' latest filing reports 5% or more of common stock, $0.0001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.

Holders

HolderPercentSharesLatestEvent date
Michael Klein20.4%10,650,000SCHEDULE 13D/A, 2025-09-112025-09-08
BOKA Group Holdings I LP5.75%12,448,810SCHEDULE 13G, 2026-03-102026-02-17
S&G Foundation5.3%11,573,878SCHEDULE 13G, 2026-06-112026-06-04
Churchill Sponsor X LLC4.9%10,725,000SCHEDULE 13D/A, 2026-02-172026-02-12
MMCAP International Inc. SPC4.8%2,000,000SCHEDULE 13G/A, 2025-08-122025-06-30
Sculptor Capital LP4.32%1,800,000SCHEDULE 13G/A, 2025-08-142025-06-30
Barclays PLC4.31%1,797,424SCHEDULE 13G/A, 2026-02-112025-12-31
Merus Global Investments, LLC4.3%1,776,660SCHEDULE 13G, 2025-10-072025-10-01
Fort Baker Capital Management LP4.1%1,722,666SCHEDULE 13G/A, 2025-11-142025-09-30
Kenneth Griffin3.9%1,622,659SCHEDULE 13G/A, 2026-02-172025-12-31
Maverick Capital, Ltd.3.6%8,069,034SCHEDULE 13D/A, 2026-05-262026-05-21
W. Grant Dollens2.2%4,691,745SCHEDULE 13G/A, 2026-06-092026-06-08
Tyler Brous0.7%1,407,392SCHEDULE 13G/A, 2026-04-282026-04-22
Empyrean Capital Partners, LP0%0SCHEDULE 13G/A, 2026-02-172025-12-31

Purpose of Transaction (Item 4)

Michael Klein

Merger Agreement As disclosed in the Current Report on Form 8-K filed by the Churchill Capital Corp X (the "Issuer") on September 8, 2025, the Issuer entered into an Agreement and Plan of Merger and Reorganization (the "Merger Agreement") by and among the Issuer, AH Merger Sub I, Inc., a Delaware corporation and direct, wholly-owned subsidiary of the Issuer ("Merger Sub I"), AH Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly-owned subsidiary of the Issuer ("Merger Sub II") and ColdQuanta, Inc., a Delaware corporation (the "Company"). Pursuant to the Merger Agreement, and on the terms and subject to the satisfaction or waiver of the conditions set forth therein, the parties thereto intend to effect a business combination transaction by which Merger Sub I will merge with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Churchill ("First Merger"), and immediately following the First Merger, the surviving corporation of the First Merger will merge with and into Merger Sub II, with Merger Sub II continuing as the surviving entity (the "Second Merger" and, together with the First Merger, the "Mergers"). The transactions contemplated by the Merger Agreement, including the PIPE Investment (as defined below), are referred to as the "Transactions." The proposed Mergers are expected to be consummated following the receipt of the required approvals by the shareholders of the Issuer and the …The first part of Item 4 of the SCHEDULE 13D/A filed 2025-09-11; the filing has the rest

Churchill Sponsor X LLC

The following amends and restates the information set forth in Item 4 of Amendment No. 1 by adding the following at the end thereof: Pursuant to the Merger Agreement, the Domestication and the Mergers were completed on February 12 and February 13, 2026, respectively. Prior to the consummation of the Domestication and the Mergers, the Reporting Person held (i) 10,350,000 Class B ordinary shares of Churchill Capital Corp X ("Churchill") and (ii) 300,000 private placement units of Churchill (each unit consisting of one Class A ordinary share, par value $0.0001 per share, of Churchill and one quarter of one warrant, with the warrant only becoming exercisable 30 days after the completion of the Mergers). Upon the Domestication and pursuant to the Merger Agreement, the securities of Churchill held by the Reporting Person automatically converted into (i) 10,650,000 shares of common stock, par value $0.0001 per share, of the Issuer ("Common Stock") and (ii) 75,000 private placement warrants of the Issuer, which will become exercisable 30 days after the completion of the Mergers. Effective upon the completion of the Mergers, the A&R Registration Rights Agreement and Advisory Agreement became effective in accordance with their terms, as previously reported.Item 4 of the SCHEDULE 13D/A filed 2026-02-17

Timeline

FiledHolderPercentFiling
2025-08-12Barclays PLC6.54%SCHEDULE 13G
2025-08-12MMCAP International Inc. SPC4.8%SCHEDULE 13G/A
2025-08-14Fort Baker Capital Management LP6.4%SCHEDULE 13G
2025-08-14Sculptor Capital LP4.32%SCHEDULE 13G/A
2025-08-14Empyrean Capital Partners, LP7.2%SCHEDULE 13G
2025-09-11Michael Klein20.4%SCHEDULE 13D/A
2025-10-07Merus Global Investments, LLC4.3%SCHEDULE 13G
2025-10-30Kenneth Griffin5.3%SCHEDULE 13G
2025-11-12Barclays PLC8.63%SCHEDULE 13G
2025-11-14Fort Baker Capital Management LP4.1%SCHEDULE 13G/A
2026-02-11Barclays PLC4.31%SCHEDULE 13G/A
2026-02-17Kenneth Griffin3.9%SCHEDULE 13G/A
2026-02-17Churchill Sponsor X LLC4.9%SCHEDULE 13D/A
2026-02-17Empyrean Capital Partners, LP0%SCHEDULE 13G/A
2026-02-18Maverick Capital, Ltd.9.2%SCHEDULE 13D
2026-02-23W. Grant Dollens11.9%SCHEDULE 13G
2026-02-27Tyler Brous14.1%SCHEDULE 13G
2026-03-10BOKA Group Holdings I LP5.75%SCHEDULE 13G
2026-04-28Tyler Brous0.7%SCHEDULE 13G/A
2026-05-26Maverick Capital, Ltd.3.6%SCHEDULE 13D/A
2026-06-09W. Grant Dollens2.2%SCHEDULE 13G/A
2026-06-11S&G Foundation5.3%SCHEDULE 13G

Tools for this story

Each opens in a new tab, filled in for Infleqtion, Inc.. With no account yet, you sign up free and land on the result.

Where this comes from

Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.

Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.

Cite this page

Permanent URL: https://mentionfox.com/stakes/infleqtion
Last updated 2026-09-27
Primary record: SEC filing 1 · SEC filing 2 · SEC filing 3 · SEC filing 4
Infleqtion, Inc. 5%+ holders: 3 at 5% or more, largest Michael Klein 20.4%. MentionFox, 2026-09-27. https://mentionfox.com/stakes/infleqtion